Wang, Y <br/><br/>
Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.  [electronic resource] 

 -  British journal of pharmacology  Aug 2007 
 - 1377-84 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjp.0707285  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Blood-Brain Barrier<br/>Brain Ischemia--drug therapy<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Enzyme-Linked Immunosorbent Assay<br/>Epoetin Alfa<br/>Erythropoietin--administration & dosage<br/>Hematinics--administration & dosage<br/>Hematocrit<br/>Infarction, Middle Cerebral Artery--drug therapy<br/>Male<br/>Microglia--drug effects<br/>Neuroprotective Agents--administration & dosage<br/>Rats<br/>Rats, Wistar<br/>Recombinant Proteins<br/>Stroke--drug therapy